ABCL Stock Analysis: Buy, Sell, or Hold?
ABCL - AbCellera Biologics Inc. Common Shares
$3.62
-0.24 (-6.22%)
▼
WAIT
LOW Confidence
Last Updated: January 30, 2026
Earnings: Feb 26, 2026
25d
Smart Money Accumulation
ABCL is down 14.6% this week, but smart money is accumulating calls. Top strike: $5 2026-04-17 with 8,175 OI. Call ratio: 83% View Scanner →
Strength: 10.0/10
Get Alerted When ABCL Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
2 traders called ABCL this week
100% bullish • 0 bearish
100% bullish • 0 bearish
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
⏸️ WAIT FOR STABILIZATION: ABCL is down 14.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
⏸️ WAIT FOR STABILIZATION: ABCL is down 14.6% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: ABCL is currently trading at $3.62, which is considered slightly low relative to its 30-day fair value range of $3.60 to $4.30.
Technical Outlook: Technically, ABCL is in a strong uptrend. The price is currently testing key support at $3.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.83 (+154.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, ABCL is in a strong uptrend. The price is currently testing key support at $3.59. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 6.2% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $9.83 (+154.7%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Fair Price Range
$3.60 -
$4.30
Company Quality Score
57/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.4%
Protect Your Profits
Holding ABCL? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-6.2%)
- BULLISH: Trading 154.7% below Wall St target ($9.83)
- WARNING: Recommendation downgraded due to -14.6% 5-day decline - wait for stabilization
Fair Price Analysis
30-Day Fair Range
$3.60 -
$4.30
Current vs Fair Value
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$3.59
Resistance Level
$4.85
Current Trend
Strong Uptrend
Fundamental Context
Forward P/E (Next Year Est.)
-5.59
Wall Street Target
$9.83
(+154.7%)
Revenue Growth (YoY)
37.6%
Earnings Growth (YoY)
45.9%
Last updated: January 31, 2026 7:54 AM ET
Data refreshes hourly during market hours. Next update: 8:54 AM
Data refreshes hourly during market hours. Next update: 8:54 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ABCL showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$66 | 46 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$112 | 52 HOLD |
|
RNA
Avidity Biosciences Inc |
STRONG BUY
15 analysts |
$75 | 62 BUY |
|
DNTH
Dianthus Therapeutics In… |
STRONG BUY
12 analysts |
$65 | 60 HOLD |
|
TVTX
Travere Therapeutics Inc |
STRONG BUY
15 analysts |
$42 | 53 HOLD |
Advanced ABCL Option Strategies
Professional options setups generated by AI based on today's ABCL price and gamma walls.
